-
Former 'Bachelorette' gets good news amid breast cancer treatment
08 Jul 2025 13:02 GMT
… good news amid her breast cancer journey.
The … was diagnosed with breast cancer in February, said … shares update on breast cancer battleThurston said in … breast cancer diagnosis, which is estrogen receptor-positive, progesterone receptor-positive and HER2 …
-
Evidence-Based Treatment Selection in Later-Line HER2+ Metastatic Breast Cancer: DESTINY-Breast12 Data and Tucatinib's Evolving Role
08 Jul 2025 12:57 GMT
Panelists discuss how trastuzumab deruxtecan has demonstrated significant central nervous system activity in DESTINY-Breast12, making it an effective option before HER2CLIMB-based regimens, even in patients without existing brain metastases.
-
Expert Insights: Later-Line Treatment Strategies for HER2+ Metastatic Breast Cancer
08 Jul 2025 12:12 GMT
… third-line therapy for HER2-positive metastatic breast cancer, treatment becomes highly individualized …
-
BriaCell Phase 2 Survival Achievement: 52% of Patients Surpass One-Year Milestone in Metastatic Breast Cancer
08 Jul 2025 11:30 GMT
… patients.” “Many patients with metastatic breast cancer unfortunately have disease progression despite … human epidermal growth factor 2 (HER2))
HER2+: Human epidermal growth factor receptor … 2 positive
HR+ HER2-: hormone receptor-positive and …
-
Study Lays Groundwork for Precision Treatment of HR+/HER2- Breast Cancer
07 Jul 2025 22:18 GMT
… Preliminary findings published in NPJ Breast Cancer
Newswise — BUFFALO, N.Y … aggressive form of metastatic breast cancer fare better than … study appears in NPJ Breast Cancer, part of the … cancer — metastatic HR+/HER2- breast cancer — may support the …
-
TROPiCS-02 Trial: Sacituzumab Govitecan in HR+/HER2– Breast Cancer
07 Jul 2025 21:05 GMT
… for hormone receptor–positive, HER2-negative metastatic breast cancer and how it influences …
-
Research identifies mechanism behind breast cancer drug resistance; offers new treatment strategies
08 Jul 2025 00:40 GMT
… advanced or metastatic HR+/HER2- breast cancer, yet resistance remains a challenge … hormonal therapy for HR+/HER2- breast cancer patients as standard care.
The … will involve treating HR+/HER2- breast cancer patients at Fox Chase with …
-
Heterogeneity Assessment of Breast Cancer Tumor Microenvironment: Multiparametric Quantitative Analysis with DCE-MRI and Discovery of Radiomics Biomarkers
07 Jul 2025 20:59 GMT
… (TME) in breast cancer significantly influences therapeutic … heterogeneity assessment in breast cancer.Keywords: breast cancer, tumor microenvironment, … biomarkers, radiogenomics
Introduction
Breast cancer remains the most … 0.001).17 HER2-enriched subtypes are …
-
Amino acid metabolism in breast cancer as a driver of disease and therapeutic target
07 Jul 2025 04:02 GMT
… like TNBC and HER2+, suggesting vulnerability to … early-stage breast cancer.
Arginine metabolism: breast tumors suppress ASS1, … Amino Acid Metabolism in Breast Cancer: Pathogenic Drivers and … Amino acid metabolism in breast cancer: pathogenic drivers and …
-
KN026/KN046 Combo Yields Durable Responses in HER2+ mBC
07 Jul 2025 22:52 GMT
… with previously treated HER2-positive advanced breast cancer, according to … patients with advanced HER2-positive breast cancer had a favorable … Gene Regulation of the Breast Tumor Center at Sun … patients with advanced HER2-positive breast cancer: a phase II …